Silo Pharma, Inc. (SILO) investor relations documents from the company's IR site: 2 presentations; latest deck 2026-05-26. Read in-app with summaries. First-party data.
I Accept: Silo Pharma (Nasdaq: SILO) is a developmental-stage biopharmaceutical company focused on novel CNS and chronic pain therapeutics using a 505(b)(2) regulatory pathway.
| Published | Type | Document |
|---|---|---|
| 2026-05-26 | Presentation | I Accept |
| 2025-03-14 | Fact sheet | Investor Fact Sheet |
SILO overview · SILO earnings · SILO financials · SILO KPIs · SILO ownership · SILO peers · SILO filings
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.